CurveBeam AI Limited (ASX:CVB)
Australia flag Australia · Delayed Price · Currency is AUD
0.0660
+0.0010 (1.54%)
At close: Mar 6, 2026

CurveBeam AI Company Description

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and Australia.

The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools.

It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks.

In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.

CurveBeam AI Limited
Country Australia
Founded 2009
Industry Medical Devices
Sector Healthcare
Employees 50
CEO Gregory Brown

Contact Details

Address:
2800 Bronze Drive
Hatfield, Pennsylvania 19440
United States
Phone 267 483 8081
Website curvebeamai.com

Stock Details

Ticker Symbol CVB
Exchange Australian Securities Exchange
Fiscal Year July - June
Reporting Currency AUD
ISIN Number AU0000289761
SIC Code 3845

Key Executives

Name Position
Gregory Wayne Brown BSc, MBA Chief Executive Officer, MD and Director
Ura Phillip Stephen Auckland Chief Financial Officer and Company Secretary
Arun Bahadur Singh Chief Operating Officer, Chief Technology Officer (CT), President of US and Europe Division and Executive Director
Dr. Aloys Mbala Co-Founder
Ali Ghasemzadeh Co-Founder
S. Turner Dean Chief Sales Officer
Vinti Singh Vice President of Marketing
Dr. Yu Peng B.S., Ph.D. Chief Technology Officer (Artificial Intelligence)
Prof. Ego Seeman Medical Director - Endocrinology